PDCD1 and cancer: Co-inhibitory proteins, such as CTLA-4 and PD-1, bind to their corresponding ligands on cancer cells, resulting in the prevention of cancer-specific T cell activation and the escape of cancer cells from immune surveillance [22,23,24].